MediSense Precision-G is firm's entry into U.S. clinical blood glucose testing market.
This article was originally published in The Gray Sheet
Executive Summary
MEDISENSE ENTERING U.S. CLINICAL BLOOD GLUCOSE TESTING MARKET WITH PRECISION-G biosensor blood glucose monitor, which will begin shipping domestically and internationally within the next two months. MediSense introduced both the Precision-G and its Precision Q-I-D, available in a home kit for patients and a hospital tray format, at the annual meeting of the American Diabetes Association the week of June 10.